CVRX Shareholder Alert: January 8, 2027 Lead Plaintiff Deadline in CVRx, Inc. Securities Class Action - Contact Levi & Korsinsky

Executive Accountability: Robert John Named in Securities Action. Shareholders allege misrepresented sales force stability and improper Barostim sales practices at CVRx, and the 18-month hiring wave the Company blamed for its guidance cut fell entirely within the former Chief Revenue Officer's tenure.

NEW YORK, Nov. 11, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors that Robert John, Chief Revenue Officer of CVRx, Inc. (Nasdaq: CVRX) from June 2024 to August 2026, is named as an individual defendant facing alleged control person liability in a securities class action on behalf of purchasers of CVRx common stock between July 25, 2023 and August 6, 2026. Find out if you could qualify to recover your per-share losses. You may also contact Joseph E. Levi, Esq. at [email protected] or (212) 363-7500.

CVRx shares lost $3.55 apiece, a 60% decline, falling from $5.94 on August 6, 2026 to $2.39 at the August 7 close on heavy volume. LEAD PLAINTIFF DEADLINE: January 8, 2027.

Robert John's Role During the Class Period

As named in the action, Mr. John served as Chief Revenue Officer beginning in June 2024 and was designated one of the Company's named executive officers in both 2024 and 2025. In August 2026, the same month CVRx cut its outlook, the Company announced he would "depart the company." When CVRx lowered guidance on August 6, 2026, it said roughly 60% of quota-carrying territory managers had joined in the prior 18 months, a window that falls entirely within his tenure.

Robert John's Alleged Role

• The complaint identifies Mr. John as one of four Officer Defendants alleged to have controlled the contents of CVRx's quarterly reports, press releases, and analyst calls.
• Plaintiffs contend that, contrary to public assurances, sales force turnover had not stabilized and productivity remained materially below expectations.
• The action asserts that much of the sales force was inexperienced, required extended ramp time, and was not yet productive enough to meet revenue projections.
• CVRx later attributed the guidance cut to the scale of turnover, a slower territory manager productivity ramp, and new hires concentrated in a subset of regions.
• The lawsuit separately claims that, to induce sales growth, CVRx and/or its employees improperly marketed Barostim and offered or paid kickbacks, issues the Justice Department is examining through a False Claims Act civil investigative demand the Company received on May 14, 2026.

Robert John's Securities Defendant Liability Under Section 20(a)

Section 20(a) of the Exchange Act allows investors to hold officers who controlled a company jointly responsible for its alleged securities violations. Plaintiffs assert that Mr. John, given his senior position and access to material nonpublic information, knew or recklessly disregarded undisclosed adverse facts and is liable as a control person for the misstatements and omissions pleaded against CVRx.

"Senior officers who lead a company's revenue function are expected to give investors an accurate picture of how its sales organization is performing. The complaint alleges that CVRx shareholders did not learn of the sales force strain or the Justice Department's False Claims Act demand until August 6, 2026. Investors who bought during the Class Period deserve a full accounting of what was known internally and when." -- Joseph E. Levi, Esq.

Submit your information here or call (212) 363-7500.

WHY LEVI & KORSINSKY — Ranked in ISS Securities Class Action Services' Top 50 Report for seven consecutive years, Levi & Korsinsky, LLP is a nationally recognized leader in shareholder rights litigation. With a team of over 70 professionals, the firm has recovered billions of dollars for investors. Investors who suffered losses have until January 8, 2027 to seek appointment as lead plaintiff.

Frequently Asked Questions About the CVRX Lawsuit

Q: How much did CVRX stock drop? A: Shares fell approximately 60%, a decline of $3.55 per share, after the Company disclosed a U.S. Department of Justice civil investigative demand under the False Claims Act and lowered its guidance due to weak sales force productivity. Investors who purchased shares during the Class Period at allegedly artificially inflated prices and suffered losses may be eligible to seek compensation.

Q: What specific misstatements does the CVRX lawsuit allege? A: The complaint alleges CVRx, Inc. made materially false or misleading statements regarding the drivers and sustainability of its Barostim revenue growth, its compliance with the False Claims Act and Anti-Kickback Statute, and the progress of its U.S. sales force realignment during the Class Period. When the Justice Department's civil investigative demand and the guidance cut tied to sales force productivity were disclosed, the stock price declined sharply.

Q: Who are the defendants named in the CVRX lawsuit? A: The complaint names CVRx, Inc. and individual defendants including senior executives who signed SEC filings, made public statements, or certified financial disclosures under Sarbanes-Oxley.

Q: What do CVRX investors need to do right now? A: Investors may gather brokerage records showing purchase dates, share quantities, and prices paid. Submit your information for a no-cost, no-obligation evaluation of your potential recovery. No immediate action is required to remain eligible as an absent class member.

Q: What is a lead plaintiff and why does it matter? A: A lead plaintiff is the investor appointed by the court to represent the entire class. Lead plaintiffs are typically investors with the largest documented losses. Being appointed does not increase individual recovery but gives direct oversight of how the case is run.

Q: What if I already sold my CVRX shares -- can I still recover losses? A: Yes. Eligibility is based on when you purchased, not whether you still hold the shares. Investors who bought during the Class Period and sold at a loss may still be eligible to participate.

Q: Do I need to go to court or give testimony? A: No. The overwhelming majority of class members never appear in court or give depositions. If there is a settlement or recovery, eligible class members generally submit a claim form to seek their portion.

Q: What if I live outside the United States? A: U.S. securities class actions generally cover purchases on U.S. exchanges regardless of the investor's country of residence.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
[email protected]
Tel: (212) 363-7500
Fax: (212) 363-7171

Attorney Advertising. Prior results do not guarantee similar outcomes.

SOURCE Levi & Korsinsky, LLP